Background The initial nonCvitamin K antagonist oral anticoagulant (NOAC) tests in
Background The initial nonCvitamin K antagonist oral anticoagulant (NOAC) tests in nonvalvular atrial fibrillation (AF) enrolled individuals with local valve pathologies. hemorrhage (HR: 0.47; 95% CI, CDH2 0.24C0.92) in AF individuals with VHD. Nevertheless, risk reduced amount of main blood loss and intracranial hemorrhage was powered by apixaban, edoxaban, and dabigatran (HR for main blood … [Read more…]